These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9434809)
41. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy. Mehta J; Keith R; Al Hasan M; Ryland B; Roy T Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201 [TBL] [Abstract][Full Text] [Related]
42. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Moss AR; Alland D; Telzak E; Hewlett D; Sharp V; Chiliade P; LaBombardi V; Kabus D; Hanna B; Palumbo L; Brudney K; Weltman A; Stoeckle K; Chirgwin K; Simberkoff M; Moghazeh S; Eisner W; Lutfey M; Kreiswirth B Int J Tuberc Lung Dis; 1997 Apr; 1(2):115-21. PubMed ID: 9441074 [TBL] [Abstract][Full Text] [Related]
43. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India. Aparna SB; Reddy VC; Gokhale S; Moorthy KV Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Javaid A; Hasan R; Zafar A; Ghafoor A; Pathan AJ; Rab A; Sadiq A; Akram CM; Burki I; Shah K; Ansari M; Rizvi N; Khan SU; Awan SR; Syed ZA; Iqbal ZH; Shaheen Z; ur Rehman N Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840 [TBL] [Abstract][Full Text] [Related]
45. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern. Aggarwal P; Singal A; Bhattacharya SN; Mishra K Int J Dermatol; 2008 Jul; 47(7):681-7. PubMed ID: 18613873 [TBL] [Abstract][Full Text] [Related]
47. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Kassa-Kelembho E; Bobossi-Serengbe G; Takeng EC; Nambea-Koisse TB; Yapou F; Talarmin A Int J Tuberc Lung Dis; 2004 May; 8(5):574-8. PubMed ID: 15137533 [TBL] [Abstract][Full Text] [Related]
48. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Al-Marri MR Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769 [TBL] [Abstract][Full Text] [Related]
50. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of acquired MDR-TB and HIV co-infection. Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236 [TBL] [Abstract][Full Text] [Related]
52. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
53. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
54. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743 [TBL] [Abstract][Full Text] [Related]
55. Drug resistance in patients with pulmonary tuberculosis. Cheung OT Can Med Assoc J; 1975 Nov; 113(9):848-9. PubMed ID: 810238 [TBL] [Abstract][Full Text] [Related]
56. Impact of immigration on pulmonary tuberculosis in Spanish children: a three-decade review. del Rosal T; Baquero-Artigao F; García-Miguel MJ; Méndez-Echevarría A; López G; Aracil FJ; de José MI; del Castillo F Pediatr Infect Dis J; 2010 Jul; 29(7):648-51. PubMed ID: 20216334 [TBL] [Abstract][Full Text] [Related]
57. Drug resistant tuberculosis in New Zealand. Mackay JB N Z Med J; 1978 Sep; 88(619):181-3. PubMed ID: 101915 [TBL] [Abstract][Full Text] [Related]
58. Atypical mycobacteria in a tuberculosis hospital. Gale GL Can Med Assoc J; 1976 Apr; 114(7):612-4. PubMed ID: 1260602 [TBL] [Abstract][Full Text] [Related]
59. Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis. Chierakul N; Saengthongpinij V; Foongladda S J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S86-90. PubMed ID: 24772584 [TBL] [Abstract][Full Text] [Related]
60. Tuberculosis of the urinary tract in southern Thailand. Tanthanuch M; Karnjanawanichkul W; Pripatnanont C J Med Assoc Thai; 2010 Aug; 93(8):916-9. PubMed ID: 20718167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]